DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Treat Clozapine-Resistant Schizophrenia Comparing Between Clozapine + Haloperidol Versus Clozapine + Electroconvulsive Therapy (ECT)

Information source: Khon Kaen University
Information obtained from ClinicalTrials.gov on December 08, 2011
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Schizophrenia

Intervention: clozapine+haloperidol (Drug); clozapine,electroconvulsive therapy (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Khon Kaen University

Official(s) and/or principal investigator(s):
Suchat Paholpak, MD, Principal Investigator, Affiliation: Department of Psychiatry.Faculty of Medicine.Khon Kaen University

Overall contact:
Suchat Paholpak, MD, Phone: 66-81-6610674, Email: suchat_p@kku.ac.th

Summary

Clozapine treatment resistant schizophrenia is still prevalent. The effectiveness of augmenting clozapine : one augmenting with haloperidol and the other with electroconvulsive therapy should be determined. This study is a randomized control trial.

Clinical Details

Official title: Treatment of Clozapine-Resistant Schizophrenia : Comparison Between Augmentation With Haloperidol and Electroconvulsive Therapy

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: PANSS , HAM-D , CGI , AIMS Scores

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

1. schizophrenic patients diagnosed with schedules for clinical assessment in neuropsychiatry ( SCAN )in accordance with DSM-IV-TR or ICD-10

2. Resistant to at least 6 weeks of clozapine treatment in therapeutic dosage

3. Voluntary to participate the research protocol expressed by signing informed consent form

Exclusion Criteria:

1. Patient does not volunteer himself or herself

2. Patient is having epilepsy, DM, cardiac disease, autistic disorder and illiterate

3. Patient is deaf, blind , dumb to obstruct good communication

Locations and Contacts

Suchat Paholpak, MD, Phone: 66-81-6610674, Email: suchat_p@kku.ac.th

Department of Psychiatry.Faculty of Medicine.KhonKaen University., Muang, KhonKaen 40002, Thailand; Recruiting
Suchat Paholpak, Phone: 66-81-6610674, Email: suchat_p@kku.ac.th
Suchat Paholpak, MD, Phone: 66-81-6610674, Email: suchat_p@kku.ac.th
Suchat Paholpak, MD, Principal Investigator
Additional Information

Starting date: June 2008
Last updated: September 15, 2008

Page last updated: December 08, 2011

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012